Skip to main content
. 2012 Dec 5;3:16. doi: 10.1186/2040-2392-3-16

Table 3.

Safety of intranasal oxytocin in the pilot clinical trial

Intranasal oxytocin Placebo
Irritability
Fatigue
Irritability (moderate)
Depressed mood
Nasal congestion/allergy symptoms (two individuals)
Cough
Query absence seizures
Worsening tics
Fatigue
Panic attack – adverse reaction to sensation of first intranasal spray administration (moderate)
Headache
 
Leg shaking
 
Increased energy